Skip to main content
Achieving Right-First-Time Cell on Muck Rack

Achieving Right-First-Time Cell

As seen in: Cell & Gene
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Achieving Right-First-Time

Contact Achieving Right-First-Time, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

06.18.24 -- Developing An mRNA Therapy For DMD With Elixirgen Therapeutics' Aki Ko

|
By Jason O. Boyd Verified, Martina de Geus, Achieving Right-First-Time Cell, Zachary S. Clauss
| Cell & Gene Verified
A helping hand is closer than you think. Your challenges drive our process development, tech transfer, automation, and scale-up solutions. Let's build a brighter future, together. Learn more Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA™ therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD.
Open in Who Shared Issue with article?
See all 1 articles